Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03579888
Title CD19-Specific T Cells Post AlloSCT
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

non-Hodgkin lymphoma

CLL/SLL

chronic lymphocytic leukemia

acute lymphoblastic leukemia

Therapies

CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T cells + Cyclophosphamide + Fludarabine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.